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TGF-b1 stimulates glucose uptake by enhancing GLUT1
expression in mesangial cells
KEN INOKI, MASAKAZU HANEDA, SHIRO MAEDA, DAISUKE KOYA, and RYUICHI KIKKAWA
The Third Department of Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan
TGF-b1 stimulates glucose uptake by enhancing GLUT1 ex- Diabetic nephropathy is characterized histologically by
pression in mesangial cells. an accumulation of extracellular matrix (ECM) proteins
Background. An increase in the expression of transforming in glomerular mesangium [1–3]. Glomerular mesangialgrowth factor-b1 (TGF-b1) has been proposed to play an im-
cells are considered to play a key role in the developmentportant role in the excessive production of extracellular matrix
of diabetic mesangial expansion, because mesangial cells(ECM) proteins seen in diabetes. Because the linkage between
glucose metabolism and ECM protein production was found were found to be capable of producing ECM proteins
in mesangial cells overexpressed with the brain-type glucose [4–7]. An enhancement of the production of type IV colla-
transporter (GLUT1), we hypothesized that TGF-b1 could gen and fibronectin was shown in mesangial cells culturedaffect glucose metabolism.
under high-glucose conditions [8, 9]. Metabolic abnormali-Methods. To prove this hypothesis, we examined the effect
ties in mesangial cells specific to diabetes have beenof TGF-b1 on glucose uptake, the first step of glucose metabo-
lism, in mesangial cells. 2-Deoxy-D-glucose (2DOG) uptake thought to contribute to the overproduction of ECM
and the expression of GLUT1 were measured in mesangial cells proteins in mesangial cells. An activation of polyol path-
exposed to various concentrations of TGF-b1. The kinetic con- way and an increase in de novo synthesis of diacylglycerol
stants were determined using 2DOG and 3-O-methyl-D-glucose
followed by the activation of protein kinase C have been(3OMG). The effect of anti–TGF-b neutralizing antibody on
proposed as candidates of metabolic abnormalities in2DOG uptake and GLUT1 mRNA was also examined in mes-
angial cells cultured under high-glucose (22.2 mm) conditions mesangial cells responsible for the overproduction of
for 72 hours. ECM proteins [9–13]. These metabolic abnormalities are
Results. TGF-b1 stimulated 2DOG uptake in mesangial cells caused by an excessive entry of glucose into mesangial
by approximately 2.5-fold in a dose- (1.25 ng/ml maximum)
cells through glucose transporters. Mesangial cells wereand time-dependent manner, with a peak stimulation at nine
found to express two types of glucose transporters, facili-hours. The increase in 2DOG uptake by TGF-b1 was com-
pletely abolished by the addition of 1 mg/ml cycloheximide, tative and sodium-coupled transporters (SGLTs) [14],
and kinetic analysis of 2DOG or 3OMG uptake revealed an and brain-type glucose transporter (GLUT1) was shown
increase in Vmax by TGF-b1. Furthermore, TGF-b1 enhanced to be a predominant isoform (abstract; Kikkawa et al,
the expression of GLUT1 mRNA from one hour, followed by
J Am Soc Nephrol 3:830, 1992) [15]. The overexpressionan enhancement of the expression of GLUT1 protein at nine
of GLUT1 in mesangial cells has been reported to resulthours. Finally, 2DOG uptake was significantly enhanced in cells
cultured under high-glucose (22.2 mm) conditions as compared in an excessive production of ECM proteins even under
with that in cells under normal glucose (5.6 mm) conditions, normal glucose conditions [16]. Therefore, clarification
and this increase in 2DOG uptake in cells under high-glucose of the regulation of GLUT1 in mesangial cells is consid-
conditions was inhibited by the addition of anti–TGF-b neu- ered to be essential to understand the mechanism oftralizing antibody.
glucose-induced overproduction of ECM proteins.Conclusions. TGF-b1 stimulates glucose uptake by enhanc-
Transforming growth factor-b1 (TGF-b1) is a multi-ing the expression of GLUT1 in mesangial cells, which leads
to the acceleration of intracellular metabolic abnormalities in functional cytokine that regulates the proliferation and
diabetes. metabolism of ECM proteins in various types of the cells
[17–19], including mesangial cells [7, 20]. Recently, an
increase in the expression of TGF-b1 has been reported
Key words: transforming growth factor-b, glucose transport, extracellu-
in glomeruli of both diabetic animals and diabetic pa-lar matrix, diabetic nephropathy, glomerular mesangial cells, brain
type glucose transporter. tients with nephropathy [21–24], and treatment with
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under high-glucose conditions, and treatment with anti– rats weighing 100 to 150 g by a sieving method as pre-
viously described [10]. Isolated glomeruli were culturedTGF-b neutralizing antibodies was again shown to pre-
vent an enhancement of the expression of ECM proteins in RPMI 1640 medium containing 20% heat-inactivated
fetal bovine serum (FBS), 100 U/ml penicillin, and 100under high-glucose conditions [7, 25]. Thus, in addition
to glucose-induced metabolic abnormalities in mesangial mg/ml streptomycin. Cultured cells were identified as
mesangial cells by morphological and biochemical char-cells, the overexpression of TGF-b1 in mesangial cells
under diabetic conditions is considered to play an impor- acters as previously described [28]. Cells at passages be-
tween 3 and 10 were used for the following experiments.tant role in the overproduction of ECM proteins. How-
ever, a linkage between TGF-b and glucose metabolism
Measurement of 2DOG uptake and kinetic analysishas not yet been elucidated in mesangial cells.
of 2DOG uptakeRecently, TGF-b1 was reported to enhance glucose
uptake and glycolysis in fibroblasts [26, 27] by inducing Mesangial cells were grown in 35 mm culture dishes
in 2 ml of RPMI 1640 medium containing 20% FBS.the expression of GLUT1 mRNA [27]. Furthermore, an
enhancement of glucose uptake resulting from the up- Confluent cells were made quiescent by reducing the
concentrations of FBS to 0.4% for 24 hours. The quies-regulation of GLUT1 mRNA was shown in mesangial
cells cultured under high-glucose conditions [15]. From cent mesangial cells were incubated in RPMI 1640 me-
dium containing 0.4% FBS with the indicated concentra-these observations, we hypothesized that TGF-b1 could
enhance glucose uptake and thus modulate the produc- tions of TGF-b1 at 378C for the indicated time interval.
The uptake of 2DOG was measured by incubating thetion of ECM proteins not only by its direct effect, but by
altering the glucose metabolism in glomerular mesangial cells in glucose-free KRP-Hepes buffer [131.2 mm NaCl,
4.71 mm KCl, 2.47 mm CaCl2, 1.24 mm MgSO4, 2.48 mmcells. To evaluate this hypothesis, we examined the effect
of TGF-b1 on glucose uptake, the first step of glucose NaH2PO4, 10 mm HEPES, and 0.5% bovine serum albu-
min (BSA), pH 7.45] with 2-[3H]DOG (1 mCi/well) andmetabolism, and the regulation of glucose transporters
in cultured mesangial cells. unlabeled 2DOG in a final concentration of 0.1 mm at
378C for five minutes [29]. Incubation was terminated by
rapid aspiration of the buffer, chilling on ice, and washing
METHODS
three times rapidly with ice-cold phosphate-buffered
Materials saline (PBS). The cells were then solubilized with 1 m
NaOH, and the radioactivity remaining in the cells wasHuman platelet TGF-b1 and anti–TGF-b neutralizing
antibody were obtained from R&D Systems (Minneapolis, determined by a liquid scintillation counter. For kinetic
analysis of 2DOG uptake, the quiescent mesangial cellsMN, USA). Purified chicken IgG was purchased from ICN
Pharmaceuticals, Inc. (Aurora, OH, USA). 2-Deoxy-D- were incubated with TGF-b1 (2.5 ng/ml) for nine hours.
The uptake of 2DOG was measured by incubating theglucose (2DOG), 3-O-methyl-D-glucose (3OMG), cyclo-
heximide, and cytochalasin B were purchased from cells in glucose-free KRP-Hepes buffer with 2-[3H]DOG
(1 mCi/well) and various concentrations of unlabeledSigma (St. Louis, MO, USA). 2-deoxy-D-[2,6-3H]glucose
(2-[3H]DOG) was purchased from Amersham Life Sci- 2DOG at 378C for five minutes. The concentrations of
cellular protein were determined using protein assay kitence (Buckinghamshire, UK). 3-O-methyl-D-[3H]glucose
(3-[3H]OMG) and [a-32P] dCTP (3000 Ci/mmol) were (Bio-Rad Laboratories, Hercules, CA, USA).
To examine the effect of high-glucose culture, mesan-purchased from NEN Research Products (Boston, MA,
USA). Anti-GLUT1 antibody and GLUT1 control pep- gial cells were chronically adapted to the conditions of
5.6 mm glucose containing 20% FBS for a long periodtide were obtained from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). Rat GLUT1 cDNA was kindly pro- of time (at least for 30 days) and then cultured in RPMI
1640 medium with either 5.6 or 22.2 mm glucose for 72vided by Dr. Yutaka Seino (University of Kyoto, Kyoto,
Japan), and rat SGLT1 cDNA was prepared by reverse hours. The concentrations of FBS were reduced to 5%,
and the culture was continued for another 24 hours.transcription-polymerase chain reaction (RT-PCR) from
total RNA of rat duodenal epithelial cells using primers Anti–TGF-b neutralizing antibody (30 mg/ml) or control
chicken IgG were added during the last 24 hours ofas follows: sense primer, 59-GTGGTACCCGTCATGA
TGGCTTCCCT-39; antisense primer, 59-TCTAGAAG culture. Cells were rinsed extensively with PBS prior to
the measurement of 2DOG uptake.GAGGATGATGCCGTTG-39. All other reagents were
of chemical grade and were purchased from standard
Kinetic analysis of 3OMG uptakesuppliers.
The uptake of 3OMG in mesangial cells was measured
Mesangial cell culture by the methods reported in fibroblasts or adipocytes
[30–32]. In brief, the quiescent mesangial cells were incu-Glomerular mesangial cells were obtained from a cul-
ture of glomeruli isolated from male Sprague-Dawley bated with TGF-b1 (2.5 ng/ml) for nine hours. The uptake
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of 3OMG was measured by incubating the cells in glucose-
and BSA-free KRP-Hepes buffer with 3-[3H]OMG
(1 mCi/well) and various concentrations of unlabeled
3OMG at 378C for 10 seconds. After the incubation, the
uptake was terminated by the addition of KRP-Hepes
buffer containing 0.3 mm phloretin (stop solution), chill-
ing on ice, and washing three times with ice-cold PBS.
The radioactivity associated with the cells at zero time
was determined by adding stop solution prior to the
addition of the radioactive 3OMG. The intracellular
radioactivity was determined by a liquid scintillation
counter as described before. The total cell volume per
dish was estimated from the equilibrium distribution of
3OMG for 15 minutes.
Fig. 1. Effect of transforming growth factor-b1 (TGF-b1) on 2-deoxy-
D-glucose (2DOG) uptake in mesangial cells. 2DOG uptake in quies-Northern blot analysis
cent mesangial cells incubated in the presence (d) or absence (s) of
2.5 ng/ml TGF-b1 for the indicated time intervals was determined. TheMesangial cells were grown in 100 mm culture dishes
data shown are mean 6 sd (N 5 4). *P , 0.01 vs. basal 2DOG uptakeand treated with TGF-b1 as described previously in this
(time 0); #P , 0.01 vs. 2DOG uptake in the cells incubated without
article. Twelve micrograms of total RNA extracted using TGF-b1 for the same period.
TRIzolt Reagent (GIBCO BRL, Grand Island, NY, USA)
were electrophoresed through a 1% agarose formaldehyde
gel and transferred on a nylon filter. The filter was prehy-
Statistical analysisbridized in Church buffer [500 mm NaPO4, pH 7.0, 5%
sodium dodecyl sulfate (SDS), 1% BSA, 1 mm ethylene- Analysis of variance followed by Scheffe’s test was
used to determine significant difference in multiple com-diaminetetraacetic acid (EDTA)] at 658C for two hours
and hybridized with radiolabeled cDNAs at 658C for 18 parisons. Comparisons between two groups were ana-
lyzed by Student’s unpaired t-test.to 24 hours in a rotating hybridization oven. The filter
was washed twice with wash buffer A (40 mm NaPO4,
pH 7.0, 5% SDS, 0.5% BSA, 1 mm EDTA) for 15 minutes
RESULTS
at 658C, twice with wash buffer B (40 mm NaPO4, pH
Effect of TGF-b1 on 2DOG uptake and kinetics of7.0, 1% SDS, 1 mm EDTA) in the same conditions, and
2DOG and 3OMG uptake in mesangial cellsexposed to Kodak X-AR film with an intensifying screen
at 2808C [33]. After stripping the radioactive probes We first examined the time course of 2DOG uptake
in mesangial cells treated with 2.5 ng/ml TGF-b1. Asfrom the filter, the filter was rehybridized with a radioac-
tive probe of acidic ribosomal phosphoprotein PO (36 shown in Figure 1, TGF-b1 stimulated 2DOG uptake in
mesangial cells by approximately 2.5-fold, with a maxi-B4) cDNA as an internal standard [34].
mal stimulation at nine hours. Although a gradual in-
Immunoblot analysis crease in 2DOG uptake was observed even in the un-
treated cells, the uptake of 2DOG in the cells treatedQuiescent confluent mesangial cells were exposed to
2.5 ng/ml of TGF-b1 at 378C for nine hours. The cells with TGF-b1 was significantly higher than that in un-
treated cells throughout the incubation periods (Fig. 1).were harvested in 500 ml of cell lysis buffer (20 mm
HEPES, pH 7.4, 1 mm EDTA, 250 mm sucrose, 1% The dose-dependent stimulation of 2DOG uptake in
mesangial cells by TGF-b1 at nine hours is shown inTriton X-100, and 1 mm phenylmethylsulfonyl fluoride)
and centrifuged at 14,000 3 g for 10 minutes. The super- Figure 2. The stimulation of 2DOG uptake in mesangial
cells by TGF-b1 was observed from 0.3125 ng/ml andnatants containing 50 mg of protein were subjected to
10% SDS-polyacrylamide gels and transferred onto Im- reached a maximal stimulation at 1.25 ng/ml.
Kinetics of 2DOG and 3OMG uptake in mesangial cellsmobilon P membranes (Millipore, Bedford, MA, USA).
The membranes were probed with anti-GLUT1 antibody were analyzed by Hanes plot analysis (Fig. 3). TGF-b1
significantly increased the Vmax for 2DOG from 1.93 6(1:500). In the competition experiments, the membranes
were treated with both GLUT1 control peptide (1:500) 0.025 to 5.36 6 0.097 nmol/mg/min (mean 6 sd, N 5 3,
P , 0.01) without affecting Km (from 0.57 6 0.06 toand anti-GLUT1 antibody. A horseradish peroxidase-
conjugated secondary antibody (1:1000) was used to 0.66 6 0.07 mm, mean 6 sd, N 5 3, P 5 NS). Similar
to 2DOG uptake, TGF-b1 significantly increased theallow the detection of immunoreactive bands using en-
hanced chemiluminescence. The intensity of desired Vmax for 3OMG from 67.57 6 1.01 to 116.50 6 0.27 pmol/
ml/second (mean 6 sd, N 5 3, P , 0.01) without affectingbands was quantitated by the densitometolic analysis.
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Effect of TGF-b1 on the expression of GLUT1
mRNA and protein
Among the facilitative glucose transporters, GLUT1
was shown to be the predominant glucose transporter
in cultured mesangial cells (abstract; Kikkawa et al, ibid)
[15]. Although the study with cytochalasin B indicates
that TGF-b1 could enhance the facilitative glucose trans-
port, the previous report suggests that mesangial cells
have two types of glucose transporters: facilitative and
sodium-coupled transporters [14]. Thus, we next exam-
ined whether TGF-b1 could stimulate the expression of
GLUT1 or SGLT-1. As shown in Figure 6 A and B,
TGF-b1 was able to enhance the expression of mRNA of
GLUT1 in a time- and dose-dependent manner, whereasFig. 2. Dose-dependent effect of TGF-b1 on 2DOG uptake in mesan-
gial cells. 2DOG uptake into mesangial cells treated with various con- mRNA of SGLT-1 could not be detected by Northern
centrations of TGF-b1 for nine hours was determined. The data shown blot analysis (data not shown). An increase in the expres-are mean 6 sd (N 5 4). *P , 0.01 vs. basal (TGF-b1 0 ng/ml).
sion of GLUT1 mRNA was observed from one hour after
treatment with TGF-b1 (Fig. 6A). The expression of
GLUT1 protein in the mesangial cells is shown in Figure 7.
Levels of the expression of 47 kDa protein, which selec-Km (from 8.38 6 0.22 to 8.50 6 0.24 mm, mean 6 sd,
tively disappeared by competition with the GLUT1 con-N 5 3, P 5 NS). These data suggest that TGF-b1 could
trol peptide (Fig. 7A), were increased by approximatelystimulate glucose uptake by increasing the number of
threefold in the cells treated with TGF-b1 for nine hours,glucose transporters without affecting the affinity of
as compared with untreated cells (Fig. 7 B, C).transporters to glucose in mesangial cells. Although the
values of Km for 3OMG were slightly different from
Effect of anti–TGF-b neutralizing antibody on 2DOGthose for 2DOG, which were concordant with the values
uptake and the expression of GLUT1reported previously in mesangial cells [15], the values of
mRNA in mesangial cells cultured underKm for 3OMG were similar to the values reported in
high-glucose conditionshuman fibroblasts [31, 32, 35].
It has been recently reported that glucose uptake isTo know the requirement of protein synthesis in TGF-
enhanced in rat mesangial cell line cultured under highb1–induced stimulation of 2DOG uptake in mesangial
concentrations of glucose, indicating the up-regulationcells, the effect of cycloheximide was examined. As
of glucose uptake by glucose [15]. To evaluate whethershown in Figure 4, the TGF-b1–induced stimulation of
endogenous TGF-b1 induced by high concentrations of2DOG uptake was completely abolished by the coincu-
glucose could be involved in this glucose-induced up-bation with 1 mg/ml of cycloheximide, suggesting that
regulation of glucose uptake, we examined the effect ofthe new protein synthesis was necessary for the TGF-
anti–TGF-b neutralizing antibody on 2DOG uptake inb1–induced stimulation of glucose uptake in mesangial
mesangial cells cultured under high-glucose conditions.cells. From these observations, TGF-b1 is considered to
Cells were cultured in the conditions similar to the previ-stimulate glucose uptake by increasing the amount of
ous report [15]. As shown in Figure 8A, 2DOG uptakeglucose transporters in the mesangial cells.
was significantly enhanced in mesangial cells culturedTo know the contribution of facilitative transporters
under high-glucose (22.2 mm) conditions as comparedto 2DOG uptake in mesangial cells, we next examined
with that in cells under normal glucose (5.6 mm) condi-the effect of cytochalasin B on 2DOG uptake. As shown
tions. The expression of TGF-b1 mRNA was also en-in Figure 5, 2DOG uptake in the cells treated with TGF-b1
hanced in cells cultured under high-glucose conditionswas significantly inhibited by 1 mm cytochalasin B to the
levels below 2DOG uptake in untreated cells. 2DOG (data not shown). This enhancement of 2DOG uptake
in cells under high-glucose conditions was significantlyuptake was almost completely abolished by 25 mm cyto-
chalasin B in both untreated cells and the cells treated inhibited by the addition of 30 mg/ml of anti–TGF-b
neutralizing antibody (Fig. 8A). As shown in Figure 8B,with TGF-b1. These results suggest that 2DOG could
be taken up by mesangial cells mainly through facilitative an increase in the expression of GLUT1 mRNA under
high-glucose conditions was also inhibited by the sametransporters, and TGF-b1 is able to enhance the facilita-
tive glucose transport. concentrations of anti–TGF-b neutralizing antibody.
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Fig. 3. Kinetic analysis of 2DOG and 3OMG
uptake in mesangial cells. 2DOG and 3OMG
uptake into mesangial cells incubated in the
presence (d) or absence (s) of 2.5 ng/ml
TGF-b1 for nine hours were determined. (A)
2DOG uptake was determined in the presence
of various concentrations of unlabeled 2DOG
ranging from 0.1 to 5.0 mm. (B) 3OMG uptake
was determined in the presence of various
concentrations of unlabeled 3OMG ranging
from 0.1 to 20 mm. The data were analyzed
by Hanes plots. The data shown are mean 6
sd (N 5 3).
Fig. 5. Effect of cytochalasin B on 2DOG uptake in mesangial cells.Fig. 4. Effect of cycloheximide on TGF-b1–induced stimulation of
Mesangial cells were incubated in media with or without 2.5 ng/ml TGF-2DOG uptake in mesangial cells. 2DOG uptake was determined in
b1 for nine hours. 2DOG uptake was determined in the presence ormesangial cells incubated in media with or without 2.5 ng/ml TGF-b1
absence of indicated concentrations of cytochalasin B in glucose-freein the presence or absence of 1 mg/ml cycloheximide for nine hours.
KRP-Hepes buffer at 378C for five minutes. The data shown are mean 6The data shown are mean 6 sd (N 5 4). *P , 0.01 vs. basal 2DOG
sd (N 5 4). *P , 0.01 vs. 2DOG uptake in the cells incubated withoutuptake (time 0); **P , 0.01 vs. 2DOG uptake in the cells incubated
TGF-b1; **P , 0.01 vs. 2DOG uptake in the cells incubated with TGF-b1;without TGF-b1 (time 9); ***P , 0.01 vs. 2DOG uptake in the cells
#P , 0.01 vs. 2DOG uptake in the cells incubated without TGF-b1.incubated with TGF-b1; #P , 0.01 vs. 2DOG uptake in the cells incu-
bated without TGF-b1 (time 9).
DISCUSSION cytokine that regulates the proliferation and the metabo-
lism of ECM proteins in various types of cells [17–19],This study clearly indicates that TGF-b1 is able to
including mesangial cells [7, 20]. However, the linkagestimulate glucose uptake, a first step of glucose metabo-
between TGF-b1 and glucose metabolism has not beenlism, in glomerular mesangial cells by inducing the ex-
examined in mesangial cells. These results clearly indicatepression of mRNA and protein of GLUT1. The results
that TGF-b1 is able to stimulate 2DOG uptake in mesan-also indicate that endogenous TGF-b1 produced by mes-
gial cells in a time- and dose-dependent manner. Anangial cells cultured under high-glucose conditions could
increase in Vmax by TGF-b1 in kinetic analysis of 2DOGstimulate glucose uptake and thus might accelerate glu-
and 3OMG uptake suggests an increase in numbers ofcose-induced metabolic abnormalities in mesangial cells.
Transforming growth factor-b1 is a multifunctional glucose transporters by TGF-b1. The TGF-b1–induced
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Fig. 6. Effect of TGF-b1 on GLUT1 mRNA expression in mesangial
cells. (A) Cells were treated with 2.5 ng/ml TGF-b1 for indicated time
intervals. Total RNA (12 mg) was subjected to Northern blot analysis.
(B) Cells were treated with indicated concentrations of TGF-b1 for six
hours. Total RNA (12 mg) was subjected to Northern blot analysis. 36
B4; human acidic ribosomal phosphoprotein PO.
increase in 2DOG uptake was abolished by the addition
of cycloheximide, indicating the requirement of new pro- Fig. 7. Effect of TGF-b1 on GLUT1 protein expression in mesangial
cells. Cells were incubated with or without 2.5 ng/ml TGF-b1 for ninetein synthesis for a TGF-b1–induced increase in 2DOG
hours, and immunoblot analysis for GLUT1 was performed. (A) Auptake. The results of the Northern blot analysis indicate
competition experiment using a GLUT1 control peptide. All lanes were
that TGF-b1 is able to stimulate the expression of mRNA loaded with 50 mg of total protein from TGF-b1–treated cells. The
antisera for the right panel were preabsorbed with GLUT1 controlfor GLUT1 in a time- and dose-dependent manner in
peptide before immunoblot analysis. (B) An immunoblot analysis of amesangial cells. Furthermore, the expression of GLUT1
GLUT1. Lanes were loaded with 50 mg of total protein from TGF-b1–
protein was also induced by TGF-b1. These results clearly untreated (C) and treated (T) cells. (C) The results of a densitometric
analysis of four independent experiments were shown. The data shownindicate that TGF-b1 stimulates glucose uptake by induc-
are mean 6 sd, N 5 4. *P , 0.05 vs. (C).ing GLUT1 mRNA and protein expressions.
Mesangial cells have been reported to express two types
of glucose transporters: facilitative and sodium-coupled
transporters [14]. Although a small amount of the expres- excessive production of ECM proteins even under normal
sion of GLUT4 was shown in mesangial cells [36], we and glucose conditions [16]. Therefore, TGF-b–induced up-
others have reported that GLUT1 is the predominant regulation of GLUT1 followed by an increase in glucose
glucose transporter in mesangial cells (abstract; Kikkawa uptake, as shown in this study, is considered to be an
et al, ibid) [15]. In this study, we examined the expression important factor in order to understand the mechanisms
of SGLT1 mRNA using cDNA prepared by RT-PCR of not only the action of TGF-b, but the regulation of
from the RNA of rat duodenal epithelial cells. However, glucose uptake in mesangial cells.
we were unable to detect SGLT1 in this study. In addi- Various growth factors, cytokines, oncogene products
tion, 2DOG uptake was almost completely inhibited by and serum were found to induce the expression of glucose
cytochalasin B in both untreated and TGF-b1–treated transporter at a transcriptional level [29, 37–40]. Two
cells, suggesting that 2DOG was taken up by mesangial distinct enhancer elements have been identified in the
cells mainly through facilitative transporters, and that 59 region and second intron of GLUT1 gene [40]. One
TGF-b1 could enhance the facilitative glucose transport. contains the homologous sequences with two 12-O-tetra-
The importance of GLUT1 in mesangial cells has been decanoylphorbol-13-acetate-responsive elements (TREs),
suggested from a recent report which found that the one serum responsive element, one cAMP-responsive
element (CRE), and three GC boxes, and the other con-overexpression of GLUT1 in mesangial cells leads to an
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Fig. 8. Effect of anti–TGF-b neutralizing an-
tibody on 2DOG uptake and the expression
of GLUT1 mRNA in mesangial cells cultured
under high glucose conditions. (A) Mesangial
cells were first maintained in RPMI 1640 me-
dium with 5.6 mm glucose containing 20% FBS
for at least 30 days and then cultured in RPMI
1640 medium with either 5.6 or 22.2 mm glu-
cose for 72 hours. The concentrations of FBS
were reduced to 5%, and the culture was con-
tinued for another 24 hours. Anti–TGF-b neu-
tralizing antibody (30 mg/ml; aT) or control
chicken IgG (30 mg/ml; control IgG) were
added during the last 24 hours of culture. The
data shown are mean 6 sd (N 5 8). *P ,
0.01 vs. 5.6 mm glucose. (B) Total RNA (12
mg) isolated from the cells under the identical
conditions of the 2DOG uptake experiment
under high-glucose condition was subjected to
Northern blot analysis. 36 B4; human acidic
ribosomal phosphoprotein PO.
tains the homologous sequences with two TREs and one uptake. In our study, 2DOG uptake and the expression
of GLUT1 mRNA were enhanced in cells cultured underCRE [40]. Because TGF-b1 has been reported to induce
its own gene expression through a TRE-like sequence, high-glucose conditions for similar durations as reported
earlier [15]. This increase in both 2DOG uptake andwhich exists within the TGF-b1 promoter [41] and the
expression of fibronectin gene through CRE sequence the expression of GLUT1 mRNA was prevented by the
addition of anti–TGF-b neutralizing antibody. Thus, in[42], TGF-b1 may regulate the GLUT1 gene expression
through these enhancer elements present in GLUT1 mesangial cells under high-glucose conditions, various
metabolic alterations, such as the activation of proteingene in mesangial cells. These possibilities need to be
examined further. kinase C, might induce the production of endogenous
TGF-b1, and TGF-b1, in turn, could stimulate glucoseVarious metabolic abnormalities secondary to hyper-
glycemia, such as an activation of the polyol pathway uptake and thus accelerate the metabolic alterations.
Recent evidence suggests that an increase in the ex-and an increase in de novo synthesis of diacylglycerol
followed by the activation of protein kinase C, have been pression of TGF-b1 in the glomeruli of both diabetic
animals and diabetic patients, as well as in mesangialproposed to play an important role in the development
of diabetic nephropathy [10, 43–46]. Excessive influx of cells cultured under high-glucose conditions, plays an
important role in the excessive production of ECM pro-glucose into mesangial cells is the first step of these
metabolic abnormalities. Recently, an increase in glucose teins seen in diabetic nephropathy [7, 21–24]. The inter-
action between TGF-b1 and GLUT1, shown in our study,uptake and in the expression of GLUT1 mRNA and
protein has been reported in mesangial cells cultured might provide the evidence for the action of TGF-b1
that is different from its direct effect on the productionunder normal glucose conditions for long periods of time
and then exposed to high concentrations of glucose [15]. of ECM proteins, and thus might be an important factor
towards understanding the mechanisms of mesangial cellWe hypothesized that TGF-b1 produced from mesangial
cells cultured under high-glucose conditions might be abnormalities that lead to the development of diabetic
nephropathy.responsible for this glucose-induced increase in glucose
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